Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

Launched by OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER · Aug 2, 2011

Keywords

ClinConnect Summary

The Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource is a clinical trial aimed at understanding and improving the lives of patients with certain blood disorders, including multiple myeloma and AL amyloidosis. Researchers are collecting valuable information from patients, such as their treatment experiences, how effective those treatments are, and how they feel throughout their illness. With this information, the team hopes to track patient progress, provide better support, and ultimately develop new treatments that can help patients live longer and healthier lives.

To participate in this trial, you need to have a diagnosis of a plasma cell dyscrasia, which is a type of blood disorder affecting plasma cells. Patients will have access to the clinical team for support, including phone and email consultations, and they may even visit the clinic in Columbus. The researchers will also keep participants informed about new clinical trials and treatment options. This study is currently recruiting patients, and it is especially important for those who may feel isolated due to the rarity of these conditions, as the team aims to provide both medical support and community connections.

Gender

ALL

Eligibility criteria

• Inclusion:
• • Diagnosis of a plasma cell dyscrasia
• Exclusion:
• • Prisoners are excluded from participation as they have no standard access to the Ohio State myeloma clinic and would impede the research objective of this protocol.